arrow
C

Cheol Kwak

seoul national university (snu)
H指数:46
被引数:9,334

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study☆

帕博利珠单抗联合恩扎卢胺对比安慰剂联合恩扎卢胺治疗化疗-naive转移性去势抵抗性前列腺癌:随机、双盲、III期KEYNOTE-641研究☆

2025-05-160
PREAI
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study☆

帕博利珠单抗联合恩扎卢胺和雄激素剥夺疗法与安慰剂联合恩扎卢胺和雄激素剥夺疗法治疗转移性激素敏感性前列腺癌:随机、双盲、III期KEYNOTE-991研究☆

2025-05-160
PREAI
Glutamyl-prolyl-tRNA synthetase (EPRS1) drives tubulointerstitial nephritis-induced fibrosis by enhancing T cell proliferation and activity
2024-05-012
PRE